Immunoglobulins and complement factors in senile plaques: An immunoperoxidase study
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Immunoperoxidase techniques were used to obtain information about the possible presence of serum factors in senile plaques. We found only in plaques consisting of an amyloid core surrounded by a corona of degenerating neurites small amounts of IgG and light chains (kappa and lambda). These immunoglobulins were principally localized in the corona and not in the central amyloid core. Further it was found that all plaques contain the complement factors C1q, C3b, C3c, C3d and C4. Senile plaques lacked C5, C3 pro-activator and properdin. The possible significance of these findings in the genesis of the senile plaques and amyloid formation is discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activated microglia along with immunoglobulins and complement components are closely associated with Aβ deposits in brains from AD patients and AD mouse models (58)(59)(60)(61)(62).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [58]
Citations
Cites
Histochemistry: Theoretical and Applied
(1953) · Journal of the American Medical Association · doi:10.1001/jama.1953.02940280072039 · Cited by 7,021
ON THE BINDING OF CONGO RED BY AMYLOID
PUCHTLER, H., SWEAT, F., & LEVINE, M. (1962) · Journal of Histochemistry & Cytochemistry · doi:10.1177/10.3.355 · Cited by 1,128
Peroxidase labelled antibody and Fab conjugates with enhanced intracellular penetration
Avrameas, S., & Ternynck, T. (1971) · Immunochemistry · doi:10.1016/0019-2791(71)90395-8 · Cited by 862
Kaplan, M. H., & Volanakis, J. E. (1974) · PubMed · Cited by 563
Glynn, L. E. (1981) · PubMed Central · Cited by 412
Interaction of C-Reactive Protein Complexes with the Complement System
Kaplan, M. H., & Volanakis, J. E. (1974) · The Journal of Immunology · doi:10.4049/jimmunol.112.6.2135 · Cited by 405
ALZHEIMER'S DISEASE AND RELATED DISORDERS
Raskind, M. A., & Peskind, E. R. (2001) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70341-2 · Cited by 161
Immuno-electron microscopic localization of immunoglobulins in amyloid fibrils of senile plaques
Ishii, T., & Haga, S. (1976) · Acta Neuropathologica · doi:10.1007/bf00685368 · Cited by 142
Ishii, T., Haga, S., & Shimizu, F. (1975) · Acta Neuropathologica · doi:10.1007/bf00689569 · Cited by 110
Research works printed but not linked: 6
- Boorsma DM, Streefkerk JG (1978) Improved method for separation of peroxidase conjugates. In: Knapp W, Holubar, K, Wick G (eds) Immunofluorescence and related staining techniques. Elsevier-North Holland Biochemical Press Amsterdam, pp 225?235
- Boorsma DM, Streefkerk JG (1976a) Some aspects of the preparation, analysis and use of peroxidase-antibody conjugates in immunohistochemistry. In: Pecters H (ed) Protides of the biological fluids, vol 24. Pergamon Press, Oxford, pp 795?802
- Davis BJ, Ornstein L (1959) High resolution enzyme localization with a new diazo reagent, ?hexazonium Pararosaniline?. J Histochem Cytochem 7:297?298
- Divry P (1927) Etude histochimique des plaques seniles. J Belge Nerol 27:643?657
- Stam FC (1965) Histochemistry of the senile involution of the brain. In: Vtn Int Congr Neuropathol Proc. Excerpta Medica, Amsterdam, pp 513?517
- Wigboldus JM (1959) Over de aard en genese van de plaques seniles. Thesis. Dijkstra's Drukkerij N.V., Groningen
Cited by
Items 101–200 of 453
Akiyama, H., Kawamata, T., Dedhar, S., & McGeer, P. L. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90067-h · Cited by 120
α-Synuclein in Parkinson’s disease: causal or bystander?
Riederer, P. F., Berg, D., Casadei, N., Cheng, F., Claßen, J., Dresel, C., Jost, W. H., Krüger, R., Müller, T., Reichmann, H., et al. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02025-9 · Cited by 128
Färber, K., Cheung, G., Mitchell, D., Wallis, R., Weihe, E., Schwaeble, W., & Kettenmann, H. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.21875 · Cited by 116
Welikovitch, L. A., Do Carmo, S., Maglóczky, Z., Malcolm, J. C., Lőke, J., Klein, W. L., Freund, T., & Cuello, A. C. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1914593117 · Cited by 116
Alzheimer's Disease: A Description of the Structural Lesions
Probst, A., Langui, D., & ULRICH, J. (1991) · Brain Pathology · doi:10.1111/j.1750-3639.1991.tb00666.x · Cited by 117
Selkoe, D. J. (1986) · Neurobiology of Aging · doi:10.1016/0197-4580(86)90055-2 · Cited by 123
The role of the immune system in Alzheimer’s disease
Wu, K., Zhang, Y.-R., Huang, Y., Dong, Q., Tan, L., & Yu, J. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101409 · Cited by 125
Pasinetti, G. M. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00113-3 · Cited by 120
Itagaki, S., Akiyama, H., Saito, H., & McGeer, P. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)91640-3 · Cited by 119
Minogue, A. M., Jones, R. S., Kelly, R. J., McDonald, C., Connor, T. J., & Lynch, M. A. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.12.026 · Cited by 119
“AD has also been associated with increased vascular permeability and protein extravasation in the brain parenchyma (Eikelenboom and Stam, 1982; Mann, 1982; Wisniewski and Kozlowski, 1982).”
BackgroundEikelenboom, P., Hoozemans, J. J., Veerhuis, R., van Exel, E., Rozemuller, A. J., & van Gool, W. A. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt118 · Cited by 109
“Aβ-associated proteins Complement proteins were the fi rst molecules detected in senile plaques in AD brains [8], two years before the identifi cation of Aβ as the core protein of the senile plaques in 1984.”
BackgroundSelf-citationEarly response of brain resident microglia to kainic acid-induced hippocampal lesions
Akiyama, H., Tooyama, I., Kondo, H., Ikeda, K., Kimura, H., McGeer, E. G., & McGeer, P. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)91447-8 · Cited by 109
The effect of insomnia on development of Alzheimer’s disease
Sadeghmousavi, S., Eskian, M., Rahmani, F., & Rezaei, N. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01960-9 · Cited by 133
The role of complement in Alzheimer’s disease pathology
Emmerling, M. R., Watson, M. D., Raby, C. A., & Spiegel, K. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00042-9 · Cited by 117
Immunity and inflammation in neurodegenerative diseases.
Cappellano, G., Carecchio, M., Fleetwood, T., Magistrelli, L., Cantello, R. M., Dianzani, U., & Comi, C. (2013) · Europe PMC (PubMed Central) · Cited by 139
(1994) · PubMed Central · Cited by 105
Autoantibodies in Neurodegenerative Diseases: Antigen-Specific Frequencies and Intrathecal Analysis
Terryberry, J. W., Thor, G. T., & Peter, J. B. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00049-9 · Cited by 104
Detection of the membrane inhibitor of reactive lysis (CD59) in diseased neurons of Alzheimer brain
McGeer, P. L., Walker, D. G., Akiyama, H., Kawamata, T., Guan, A. L., Parker, C. J., Okada, N., & McGeer, E. G. (1991) · Brain Research · doi:10.1016/0006-8993(91)90071-3 · Cited by 105
Boche, D., & Nicoll, J. A. R. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00134.x · Cited by 104
“More than 20 years ago, immunoglobulin (Ig)-G was seen by light and electron microscopy in the AD brain to be co-localized with neuritic plaques (28, 52, 53); however, the role of IgG in the AD process, including in plaque formation, remains unclear.”
BackgroundHead, E., Azizeh, B. Y., Lott, I. T., Tenner, A. J., Cotman, C. W., & Cribbs, D. H. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0380 · Cited by 103
Blood-brain barrier in Alzheimer dementia and in non-demented elderly: An immunocytochemical study
Alafuzoff, I. I., Adolfsson, R., Grundke, I., & Winblad, B. G. (1987) · Acta Neuropathologica · doi:10.1007/bf00693782 · Cited by 105
“and complement factors in plaques in A D / S D A T [13].”
BackgroundRegenerative potential of allopregnanolone
Wang, J. M., Liu, L., Irwin, R. W., Chen, S., & Brinton, R. D. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.08.010 · Cited by 110
Lemere, C. A., Maron, R., SPOONER, E. T., Grenfell, T. J., Mori, C., Desai, R. V., Hancock, W. W., Weiner, H. L., & Selkoe, D. J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06943.x · Cited by 101
β-Amyloid Converts an Acute Phase Injury Response to Chronic Injury Responses
Cotman, C. W., Tenner, A. J., & Cummings, B. J. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00117-0 · Cited by 108
Complement-Mediated Events in Alzheimer’s Disease: Mechanisms and Potential Therapeutic Targets
Tenner, A. J. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901068 · Cited by 108
“As early as 1982, complement proteins were found associated with amyloid plaques in human AD brain (86).”
BackgroundThe complement cascade in Alzheimer’s disease: a systematic review and meta-analysis
Krance, S. H., Wu, C., Zou, Y. Z., Mao, H., Toufighi, S., He, X., Pakosh, M. T., & Swardfager, W. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0536-8 · Cited by 108
Eikelenboom, P., Rozemüller, A. J. M., & Muiswinkel, F. L. V. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6920 · Cited by 105
Self-citationRozemüller, A. J. M., Stam, F. C., & Eikelenboom, P. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90759-3 · Cited by 98
Self-citationFrom development to dysfunction: Microglia and the complement cascade in CNS homeostasis
Zabel, M. K., & Kirsch, W. M. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.02.001 · Cited by 97
DeKosky, S. T., Ikonomovic, M. D., Wang, X., Farlow, M., Wisniewski, S., Lopez, O. L., Becker, J. T., Saxton, J., Klunk, W. E., Sweet, R., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10414 · Cited by 97
Rozemüller, A. J. M., Abbink, J. J., Kamp, A. M., Stam, F. C., Hack, C. E., & Eikelenboom, P. (1991) · Acta Neuropathologica · doi:10.1007/bf00294446 · Cited by 97
“Complement components, which are also found in plaques [14], can also be produced by glial cells [25].”
BackgroundSelf-citationNeuroinflammation, Its Role in Alzheimer's Disease and Therapeutic Strategies
Király, M., Foss, J. F., & Giordano, T. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.109 · Cited by 121
“Eikelenboom et al. demonstrated in 1982 that senile plaques contain the complement factors C1q, C3b, C3c, C3d and C4, (81) again supporting the hypothesis that the complement system and inflammation play a role in AD.”
Arélin, K., Kinoshita, A., Whelan, C. M., Irizarry, M. C., Rebeck, G. W., Strickland, D. K., & Hyman, B. T. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00203-6 · Cited by 77
Hewett, S. J., Bell, S. C., & Hewett, J. A. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.011 · Cited by 100
Yin and Yang: complement activation and regulation in Alzheimer’s disease
Shen, Y., & Meri, S. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.08.001 · Cited by 101
Selkoe, D. J. (1989) · Neurobiology of Aging · doi:10.1016/0197-4580(89)90072-9 · Cited by 90
Garlind, A., Brauner, A., Höjeberg, B., Basun, H., & Schultzberg, M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01092-6 · Cited by 95
Eikelenboom, P., Veerhuis, R., van Exel, E., J.M. Hoozemans, J., J.M. Rozemuller, A., & A. van Gool, W. (2011) · Current Alzheimer Research · doi:10.2174/156720511795256080 · Cited by 88
Self-citationReactive astrocytes and α1-antichymotrypsin in Alzheimer's disease
Abraham, C. R. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00302-5 · Cited by 95
Ager, R. R., Fonseca, M. I., Chu, S., Sanderson, S. D., Taylor, S. M., Woodruff, T. M., & Tenner, A. J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06595.x · Cited by 86
Reactions of the Immune System in Chronic Degenerative Neurological Diseases
McGeer, P. L., McGeer, E. G., Kawamata, T., Yamada, T., & Akiyama, H. (1991) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100032479 · Cited by 86
Walker, L. C. (2020) · Free Neuropathology · doi:10.17879/freeneuropathology-2020-3025 · Cited by 171
Korolainen, M. A., Nyman, T. A., Nyyssönen, P., Hartikainen, E. S., & Pirttilä, T. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.078014 · Cited by 85
Nanomaterials toward the treatment of Alzheimer’s disease: Recent advances and future trends
Zeng, H., Qi, Y., Zhang, Z., Liu, C., Peng, W., & Zhang, Y. (2021) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.01.014 · Cited by 83
Microglia, Alzheimer's Disease, and Complement
Crehan, H., Hardy, J., & Pocock, J. (2012) · International Journal of Alzheimer's Disease · doi:10.1155/2012/983640 · Cited by 84
“Early studies identified complement proteins of the classical pathway, such as factor C1q, in AD brains [35], and subsequent studies established the presence of all of the native complement proteins as well as their activation products C4d, C3d, and MAC in AD brain [2].”
BackgroundSimon, E., Obst, J., & Gomez-Nicola, D. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2018.01.059 · Cited by 83
Luchena, C., Zuazo-Ibarra, J., Alberdi, E., Matute, C., & Capetillo-Zarate, E. (2018) · Mediators of Inflammation · doi:10.1155/2018/2530414 · Cited by 82
“Components of the classical complement pathway have been associated with senile plaques [79, 80], fibrillar Aβ, NFT, and dystrophic neurites [11, 63, 64, 81–85].”
An immunohistochemical study on cerebral vascular and senile plaque amyloid in Alzheimer’s dementia
Eikelenboom, P., & Stam, F. C. (1984) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02890185 · Cited by 83
Self-citationComplement in Alzheimer's disease: opportunities for modulating protective and pathogenic events
Tenner, A. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00301-3 · Cited by 81
Eikelenboom, P., Rozemüller, A. J. M., Kraal, G., Stam, F. C., McBride, P., Bruce, M. E., & Fraser, H. (1991) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02899564 · Cited by 81
Self-citationLoeffler, D. A. (2023) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-230025 · Cited by 79
Blom, M. A. A., van Twillert, M. G. H., de Vries, S. C., Engels, F., Finch, C. E., Veerhuis, R., & Eikelenboom, P. (1997) · Brain Research · doi:10.1016/s0006-8993(97)01204-3 · Cited by 83
Self-citationNeuroinflammation and Alzheimer Disease: Clinical and Therapeutic Implications
Eikelenboom, P., Rozemuller, A. J. M., Hoozemans, J. J. M., Veerhuis, R., & van Gool, W. A. (2000) · Alzheimer Disease and Associated Disorders · doi:10.1097/00002093-200000001-00009 · Cited by 78
Self-citationEikelenboom, P., Zhan, S., Kamphorst, W., van der Valk, P., & Rozemüller, A. J. M. (1994) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00190565 · Cited by 83
Self-citationThe role of complement in disorders of the nervous system
Morgan, B. P., Gasque, P., Singhrao, S. K., & Piddlesden, S. J. (1997) · Immunopharmacology · doi:10.1016/s0162-3109(97)00059-3 · Cited by 78
Prasad, K. N., Cole, W. C., & Prasad, K. C. (2002) · Journal of the American College of Nutrition · doi:10.1080/07315724.2002.10719249 · Cited by 84
“They include excess amounts of free Zn and Cu [98], iron and aluminum [108] and complement proteins [28].”
BackgroundRoles of the Complement System in Human Neurodegenerative Disorders
Gasque, P., Neal, J. W., Singhrao, S. K., McGreal, E. P., Dean, Y. D., van Beek, J., & Morgan, B. P. (2002) · Molecular Neurobiology · doi:10.1385/mn:25:1:001 · Cited by 82
“Eikelenboom and Stam in 1982 (8) were the first to demonstrate the presence of C proteins in senile amyloid plaques and NFTs in AD brains using immunohistochemical techniques and subsequently numerous groups have also reported the association of C proteins of the CP in AD pathology (see Table 2).”
BackgroundInflammation and Alzheimer disease
Aisen, P. S. S. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815208 · Cited by 81
Charge-based binding of complement component C1q to the Alzheimer amyloid beta-peptide.
Webster, S. M., Bonnell, B. S., & Rogers, J. (1997) · Europe PMC (PubMed Central) · Cited by 86
Evaluation of Selective COX-2 Inhibitors for the Treatment of Alzheimer's Disease
Aisen, P. S. S. (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00374-3 · Cited by 83
Veerhuis, R., van der Valk, P., Janssen, I., Zhan, S., Eikelenboom, P., & Nostrand, W. E. V. (1995) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00192116 · Cited by 83
Self-citationPrasad, K. N., Hovland, A. R., Cole, W. C., Prasad, K. C., Nahreini, P., Edwards-Prasad, J., & Andreatta, C. P. (2000) · Clinical Neuropharmacology · doi:10.1097/00002826-200001000-00002 · Cited by 74
Brennan, F. H., Lee, J. D., Ruitenberg, M. J., & Woodruff, T. M. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.03.015 · Cited by 76
Interconnection Between Brain and Retinal Neurodegenerations
Jindal, V. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8733-6 · Cited by 80
Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques
van Horssen, J., Kleinnijenhuis, J., Maass, C., Rensink, A. A. M., Otte‐Höller, I., David, G., van den Heuvel, L. P. W. J., Wesseling, P., de Waal, R. M. W., & Verbeek, M. M. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00010-6 · Cited by 81
You, M., Chen, Y., Pan, Y., Liu, Y.-C., Tu, J., Wang, K., & Hu, F. (2018) · Mediators of Inflammation · doi:10.1155/2018/7834381 · Cited by 83
“Since Eikelenboom and Stam first found the inflammatory mediators in AD brains after 1982, more and more scientists started to explore the relationship between inflammation and AD [2].”
Do Delirium and Alzheimer’s Dementia Share Specific Pathogenetic Mechanisms?
Eikelenboom, P., & Hoogendijk, W. J. G. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017162 · Cited by 73
Self-citationZhan, S., Veerhuis, R., Kamphorst, W., & Eikelenboom, P. (1995) · Neurodegeneration · doi:10.1016/1055-8330(95)90018-7 · Cited by 78
Self-citationDetection of soluble forms of the β-amyloid precursor protein in human plasma
Podlisny, M. B., Mammen, A. L., Schlossmacher, M. G., Palmert, M. R., Younkin, S. G., & Selkoe, D. J. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90635-z · Cited by 70
Complement C1q and C3 mRNA expression in the frontal cortex of Alzheimer's patients
Fischer, B. E., Schmoll, H., Platt, D., Popa‐Wagner, A., Riederer, P. F., & Bauer, J. (1995) · Journal of Molecular Medicine · doi:10.1007/bf00202265 · Cited by 68
Chen, S., Frederickson, R. C. A., & Brunden, K. R. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00103-0 · Cited by 73
Developmental origins of aging in brain and blood vessels: an overview
Finch, C. E. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.03.015 · Cited by 75
The Immunopathology of Alzheimer's Disease and Some Related Disorders
Kalaria, R. N. (1993) · Brain Pathology · doi:10.1111/j.1750-3639.1993.tb00761.x · Cited by 69
Plaque complement activation and cognitive loss in Alzheimer's disease
Loeffler, D. A., Camp, D. M., & Bennett, D. A. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-9 · Cited by 68
“Complement immunoreactivity is present in the Alzheimer's disease (AD) brain on amyloid-beta (Aβ) – containing plaques, neurofibrillary tangles (NFTs), neuropil threads, and dystrophic neurites [1-4].”
BackgroundNeuropathology and the Neuroinflammation Idea
Mrak, R. E. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1158 · Cited by 66
“Comple-mentdepositioninA β plaqueswasreportedin1982[5], but the presence of activated complementwas not noted until 1989 [6,7].”
The Importance of Complement-Mediated Immune Signaling in Alzheimer’s Disease Pathogenesis
Batista, A. F., Khan, K. A., Papavergi, M.-T., & Lemere, C. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020817 · Cited by 65
“It has been shown that the classical complement proteins C1q, C3, and C4 co-localize with A β plaques and NFTs in memory-related areas in the AD brain [33,65,66,97,99].”
BackgroundHayes, A., Thaker, U., Iwatsubo, T., Pickering-Brown, S. M., & Mann, D. M. A. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00888-1 · Cited by 71
Emerging perspectives on mitochondrial dysfunction and inflammation in Alzheimer’s disease
Yoo, S., Park, J., Kim, S., & Jung, Y. (2020) · BMB Reports · doi:10.5483/bmbrep.2020.53.1.274 · Cited by 65
Brazil, M. I., Chung, H., & Maxfield, F. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000937200 · Cited by 65
Ca2+-dependent Binding of Human Serum Amyloid P Component to Alzheimer's β-Amyloid Peptide
Hamazaki, H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10392 · Cited by 65
Complement Activation in Chromosome 13 Dementias
Rostagno, A., Revesz, T., Lashley, T., Tomidokoro, Y., Magnotti, L., Braendgaard, H., Plant, G., Bojsen-Møller, M., Holton, J., Frangione, B., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206448200 · Cited by 64
O’Barr, S. A., & Cooper, N. R. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00291-5 · Cited by 69
Can inflammation be resolved in Alzheimer’s disease?
Zhu, M., Wang, X., Sun, L., Schultzberg, M., & Hjorth, E. (2018) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286418791107 · Cited by 62
The complement system in central nervous system diseases
Rus, H., Cudrici, C., David, S., & Niculescu, F. (2006) · Autoimmunity · doi:10.1080/08916930600739605 · Cited by 61
“Eikelenbson and Stam were the first to show the presence of C1q, C3, and C4 in senile plaques in association with immunoglobulins [77].”
BackgroundWhat does complement do in Alzheimer’s disease? Old molecules with new insights
Shen, Y., Yang, L., & Li, R. (2013) · Translational Neurodegeneration · doi:10.1186/2047-9158-2-21 · Cited by 60
Receptors for pro‐resolving mediators are increased in Alzheimer's disease brain
Emre, C., Hjorth, E., Bharani, K., Carroll, S., Granholm, A., & Schultzberg, M. (2020) · Brain Pathology · doi:10.1111/bpa.12812 · Cited by 60
Regeneration in a Degenerating Brain: Potential of Allopregnanolone as a Neuroregenerative Agent
Wang, J., Irwin, R. W., Liu, L., Chen, S., & Brinton, R. D. (2007) · Current Alzheimer Research · doi:10.2174/156720507783018262 · Cited by 62
“In AD brains, compacted A plaques are often associated with activated astrocytes and microglia and a variety of cytokines and other inflammatory proteins secreted by activated astrocytes or microglia, including Clq, C3, C9, C3d, and C4d, which are found in brains from human AD patients and mouse models of AD [48-50].”
BackgroundThe Correlation between Inflammatory Biomarkers and Polygenic Risk Score in Alzheimer’s Disease
Morgan, A. R., Touchard, S., O’Hagan, C., Sims, R., Majounie, E., Escott-Price, V., Jones, L., Williams, J., & Morgan, B. P. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160889 · Cited by 59
The complement system in neurodegenerative diseases
Nimmo, J., Byrne, R. A. J., Daskoulidou, N., Watkins, L. M., Carpanini, S. M., Zelek, W. M., & Morgan, B. P. (2024) · Clinical Science · doi:10.1042/cs20230513 · Cited by 61
“Early studies demonstrated the presence of complement proteins in cerebrospinal fluid (CSF) and in brain extracts, but the sources of these were uncertain – were they made locally or infiltrated from the periphery [1–3]?”
BackgroundApolipoprotein E isoform‐dependent microglia migration
Cudaback, E., Li, X., Montine, K. S., Montine, T. J., & Keene, C. D. (2011) · The FASEB Journal · doi:10.1096/fj.10-176891 · Cited by 58
Antibodies to viral antigens, xenoantigens, and autoantigens in Alzheimer’s disease
Ounanian, A., Seigneurin, J. ‐., Guilbert, B., Avrameas, S., & Renverez, J. ‐. (1990) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.1860040510 · Cited by 58
Yasojima, K., McGeer, E. G., & McGeer, P. L. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01514-0 · Cited by 63
Apoptosis, Neurotrophic Factors and Neurodegeneration
Dragunow, M., MacGibbon, G. A., Lawlor, P. A., Butterworth, N. J., Connor, B. J., Henderson, C. E., Walton, M. R., Woodgate, A.-M., Hughes, P. E., & Faull, R. L. M. (1997) · Reviews in the Neurosciences · doi:10.1515/revneuro.1997.8.3-4.223 · Cited by 64
Lee, D. C., Rizer, J., Hunt, J. B., Selenica, M. ‐. B., Gordon, M. N., & Morgan, D. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12002 · Cited by 57
Complement proteins and complement inhibitors in Alzheimer's disease
McGeer, P. L., & McGeer, E. G. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80045-m · Cited by 57
Hao, W., Liu, Y., Liu, S., Walter, S., Grimm, M. O., Kiliaan, A. J., Penke, B., Hartmann, T., Rübe, C. E., Menger, M. D., et al. (2011) · Brain · doi:10.1093/brain/awq325 · Cited by 56
“Increased expression of inflammatory mediators has been observed in post-mortem Alzheimer’s disease brains (Eikelenboom and Stam, 1982; McGeer et al., 1988) and positron emission tomography studies have shown an association between microglial activation and Alzheimer’s disease progression…”
BackgroundRehiman, S. H., Lim, S. M., Neoh, C. F., Majeed, A. B. A., Chin, A.-V., Tan, M. P., Kamaruzzaman, S. B., & Ramasamy, K. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101066 · Cited by 55
Tanskanen, M., Lindsberg, P. J., Tienari, P. J., Polvikoski, T., Sulkava, R., Verkkoniemi, A., Rastas, S., Paetau, A., & Kiuru‐Enari, S. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00652.x · Cited by 55
Neuroinflammation in Alzheimer's disease: protector or promoter?
Žilka, N., Ferencĭk, M., & Hulín, I. (2006) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03656856 · Cited by 69
Phytochemicals: A Promising Alternative for the Prevention of Alzheimer’s Disease
Koul, B., Farooq, U., Yadav, D., & Song, M. (2023) · Life · doi:10.3390/life13040999 · Cited by 64
Metadata
- Authors
- Eikelenboom, P., & Stam, F. C.
- Affiliations
- Vrije Universiteit Amsterdam (NL)
- ORCID
- Eikelenboom, P.
- Venue
- Acta Neuropathologica
- Published
- 1982
- Volume
- 57
- Issue
- 2-3
- Pages
- 239-242
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2312933856
- Cited by
- 454
- References
- 24
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 15 · 2023: 10 · 2022: 8 · 2021: 12 · 2020: 23 · 2019: 13 · 2018: 13 · 2017: 11 · 2016: 9 · 2015: 7 · 2014: 16 · 2013: 7 · 2012: 11
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Keywords
- amyloid plaques, Alzheimer's disease, immunoglobulins, complement proteins, amyloid core, neurite degeneration, IgG, kappa light chain, lambda light chain, C1q, C3b, C3c, C3d, C4, C5, properdin, amyloid fibril formation
- MeSH terms
- Alzheimer Disease, Amyloid, Cerebral Cortex, Complement System Proteins, Dementia, Humans, Immunoglobulin G, Immunoenzyme Techniques, Immunoglobulins, Immunoglobulin Fc Fragments, Immunoglobulin gamma-Chains
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.